Literature DB >> 17231

Drugs for peptic ulcer. Invited commentary.

M I Grossman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 17231     DOI: 10.1007/BF01654718

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  7 in total

1.  BIOGASTRONE IN INPATIENT TREATMENT OF GASTRIC ULCER: A DOUBLE-BLIND STUDY.

Authors:  W R MIDDLETON; A R COOKE; D STEPHEN; A P SKYRING
Journal:  Lancet       Date:  1965-05-15       Impact factor: 79.321

2.  The value of a histamine H2-receptor antagonist in the management of patients with the Zollinger-Ellison syndrome.

Authors:  C T Richardson; J H Walsh
Journal:  N Engl J Med       Date:  1976-01-15       Impact factor: 91.245

3.  Complications of carbenoxolone therapy.

Authors:  G J Davies; J Rhodes; B J Calcraft
Journal:  Br Med J       Date:  1974-08-10

4.  Treatment of gastric ulcer with carbenoxolone: antagonistic effect of spironolactone.

Authors:  R Doll; M J Langman; H H Shawdon
Journal:  Gut       Date:  1968-02       Impact factor: 23.059

5.  The medical treatment of gastric and duodenal ulcer.

Authors:  M J Langman
Journal:  Postgrad Med J       Date:  1968-08       Impact factor: 2.401

6.  Carbenoxolone sodium in the treatment of gastric ulcer with special reference to side-effects.

Authors:  A G Turpie; T J Thomson
Journal:  Gut       Date:  1965-12       Impact factor: 23.059

7.  Proceedings: The prevention of relapse in duodenal ulceration by long-term nocturnal metiamide treatment.

Authors:  M H Thompson; C W Venables
Journal:  Gut       Date:  1976-05       Impact factor: 23.059

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.